azomycin has been researched along with Heart Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, K; Kawana, A; Kurane, I; Maeda, T; Mikita, K; Miura, S; Miyahira, Y; Osa, M; Sayama, Y | 1 |
| Avezum, Á; Cordeiro Mattos, AJ; Oliveira, GB | 1 |
| Friedman, JM; Garg, NJ; Lora, JN; Machado, FS; Moraes, DN; Nagajyothi, J; Nunes, MC; Ribeiro, AL; Spray, DC; Tanowitz, HB; Weiss, OS | 1 |
| Komajda, M; Ruschitzka, F | 1 |
| Bierrenbach, AL; Cardoso, CS; Cunha-Neto, E; de Oliveira, LC; Ferreira, AM; Ferreira, JE; Haikal, DS; Oliveira, CD; Reingold, AL; Ribeiro, AL; Sabino, EC | 1 |
| Alvarez, MG; Armenti, A; Bertocchi, G; Lococo, B; Petti, M; Vigliano, C; Viotti, R | 1 |
| Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
2 review(s) available for azomycin and Heart Failure
| Article | Year |
|---|---|
Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review.
Topics: Animals; Chagas Disease; Chronic Disease; Female; Heart Failure; Humans; Middle Aged; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Developments in the management of Chagas cardiomyopathy.
Topics: Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Disease Management; Electrocardiography; Heart Failure; Humans; Nanotechnology; Nitroimidazoles; Stem Cell Transplantation; Trypanocidal Agents; Vaccines | 2015 |
6 other study(ies) available for azomycin and Heart Failure
| Article | Year |
|---|---|
Perspectives in Chagas disease treatment.
Topics: Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chagas Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease Management; Heart Failure; Humans; Insect Control; Insect Vectors; Nifurtimox; Nitroimidazoles; Thromboembolism; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
The year in cardiology 2015: heart failure.
Topics: Alcohol Drinking; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Chagas Cardiomyopathy; Chronic Disease; Diabetes Mellitus, Type 2; Genetic Therapy; Heart Failure; Humans; Hypoglycemic Agents; Nitroimidazoles; Respiration, Artificial; Risk Factors; Sleep Apnea, Central; Trypanocidal Agents | 2016 |
Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.
Topics: Aged; Biomarkers; Brazil; Chagas Cardiomyopathy; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Heart Failure; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroimidazoles; Peptide Fragments; Population Surveillance; Predictive Value of Tests; Prognosis; Prospective Studies; Quality of Life; Socioeconomic Factors | 2016 |
Chagas' disease and its toll on the heart.
Topics: Acute Disease; Arrhythmias, Cardiac; Brazil; Chagas Cardiomyopathy; Chronic Disease; Defibrillators, Implantable; Heart Failure; History, 20th Century; Humans; Nitroimidazoles; Nobel Prize; Trypanocidal Agents | 2009 |
[Clinical predictors of chronic chagasic myocarditis progression].
Topics: Adult; Chagas Cardiomyopathy; Disease Progression; Echocardiography; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocarditis; Nitroimidazoles; Prognosis; Proportional Hazards Models; Risk Factors; Time Factors; Trypanocidal Agents | 2005 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |